Serum Cytokeratin 19 Fragment, CK19-2G2, as a Newly Identified Biomarker for Lung Cancer
Jia Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Qi(Hong Kong Baptist University), Fang Lv(Liaoning Normal University), Zongyong Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jia Li(Jilin University)
Cited by 12
Related Papers
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115